PET/MR in Breast Cancer

摘要: Breast cancer is an international public health concern in which optimal treatment plan requires a precise staging. Both MRI and PET imaging techniques have made significant progress the last decades with constant improvements that both modalities clinically relevant several stages of breast management follow-up. On one hand, specific permits high diagnostic accuracy for local tumor staging, whole-body can also be great use distant eventually accompanied by organ-specific sequences. Moreover, many different sequences performed, including functional MRI, letting us foresee important characterization future. contrary, (18)F-FDG-PET has performance detection metastases, other tracers currently under development may profoundly affect future better determination types cancers allowing personalized treatments. As consequence PET/MR promising emerging technology, it foreseeable cases where data are needed, hybrid acquisition justified when available. However, at this stage deployment such scanners clinical setting, more needed to demonstrate their added value beyond just patient comfort having undergo single examination instead two, higher confidence interpretation these co-registered images. Optimized protocols still being developed prone provide efficient potential improvement accuracy. More convincing studies larger number patients as well cost-effectiveness needed. This article provides insights into current state-of-the-art gives outlook on developments applications